Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer Clinical Trial
Official title:
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
Assess the safety and feasibility of local oncological drug delivery into the bronchial wall
after recanalization of subjects with malignant airway obstruction. Safety and feasibility
(technical success) will be assessed.
This localized delivery is intended as an adjunct therapy and all subjects will receive
standard of care oncology therapy as determined by their treating physicians.
n/a